<DOC>
	<DOCNO>NCT02088567</DOCNO>
	<brief_summary>The overall objective study evaluate effectiveness dHACM reduce scar tissue formation total knee replacement patient .</brief_summary>
	<brief_title>Amniotic Membrane Total Knee Replacements Reduce Scarring</brief_title>
	<detailed_description />
	<mesh_term>Cicatrix</mesh_term>
	<criteria>1 . Are adults age 18 old . 2 . Are diagnose advanced osteoarthritis determine clinical exam necessitate total knee replacement . 3 . Have willingness comply followup examination . 4 . Have ability give full write consent . 1 . Has previous total partial joint replacement perform site 2 . Has plan bilateral procedure time . Bilateral patient enrol procedure stag . 3 . Has sign symptom disease could result allograft failure , experience allograft failure past . 4 . Has use investigational drug ( ) therapeutic device ( ) within 30 day precede screening . 5 . Is pregnant may become pregnant study . 6 . Is prisoner . 7 . Has condition ( ) seriously compromise subject 's ability participate study , know history poor adherence medical treatment . 8 . Is currently take medication could affect allograft incorporation ( supervise physician 's discretion ) . 9 . Is confine bed wheelchair . 10 . Has clinical sign symptom local infection site . 11 . Has autoimmune disease know history Acquired Immunodeficiency Syndrome ( AIDS ) HIV . 12 . Has current diagnosis cancer site . 13 . Has prior radiation therapy treatment site . 14 . Is currently take anticoagulant therapy . 15 . Is unable sign understand inform consent . 16 . Has history drug alcohol abuse within last 12 month . 17 . Is allergic Aminoglycoside antibiotic ( gentamicin and/or streptomycin ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>